March 28, 2014

University of Alabama at Birmingham receives $35 million for infectious disease research

The University of Alabama at Birmingham has been awarded $35 million from the National Institute of Allergy and Infectious Diseases to establish a research center focused on developing new drug therapies for global infectious disease threats such as influenza, West Nile and Middle East respiratory syndrome, or MERS, coronavirus.

UAB in the News

 
 
Back to Top